Human Tetanus Immunoglobulin

Description

Human tetanus immunoglobulin is a liquid preparation containing not less than 100IU/ml of anti-tetanus antibody and more than 90% of immunoglobulin in the total protein. It is prepared from pooled anti-tetanus-antibodies-rich plasma of healthy donors immunized with hepatitis B vaccine and subsequently with adsorbed tetanus vaccine, by cold ethanol fractionation or other separation method approved by the NCA, followed b viral inactivation. The product is specific immunoglobulin for intramuscular injection, used for prevention and treatment of tetanus.

Specifications

250IU. 1vial/box; 200vial/carton.

Therapeutic Indications

Tetanus immunoglobulin, rather than vaccine, should be administered to boost immunity following a high-risk tetanus-prone injury

Posology and Administration

Must be taken according to the doctor’s direction in order for the patients to benefit.

Contraindications

Contact local hospital or doctor for details.

Adverse effect and treatment

Contact local hospital or doctor for details.

Precautions

Comply to doctor’s direction.

Storage and Validity

Store and ship at 2-8℃, protected from light. Product shall be used before the expiry date stated on the label of cartons (or container).